The theoretical and practical considerations of 
regarding the choice of drug nor any standardized dosage scheme applicable to all patients. Furthermore, the patient has to be kept under close observation over several days while the dose given and effect caused are titrated. Only a small margin separates the therapeutic from toxic effects, and many of the antidysrhythmic drugs also have important negative inotropic and dromotropic effects. Should toxic manifestations emerge, they may be more serious than the original rhythm disturbance for which the drug was given, and paradoxically drug overdosage may well depress the normal sinus mechanism, thereby inhibiting reversion to sinus rhythm.
In contrast, an electric shock across the chest and myocardium causes momentary depolarization of the majority of heart fibers, terminates the ectopic rhythm, and allows the sinus node to be reestablished as the normal pacemaker.
Early History
In papers dealing with the effects of electric current on the myocardium, Prevost and Battellil 2 noted almost as an afterthought that direct current shock across the heart would end ventricular fibrillation in dogs. This important fact continued generally unrecognized or seemed largely forgotten until Kouwenhoven, Hooker, and Langworthy3 4 and Ferris, King, Spence, and Williams5 undertook detailed studies on the effects of electricity on the heart and reported the following important conclusions: (1) current rather than voltage is a proper criterion for shock intensity, (2) the passage of electrical current across the heart may precipitate ventricular fibrillation even in the absence of any recognizable myocardial damage, and (3) death will follow unless this is successfully treated by another shock within a few minutes.
Subsequently, pioneer work into the use of capacitor discharge (direct current) for clinical application was undertaken in the Soviet Union between 1935 and 1950;6 these studies can be regarded as an important inspiration to later investigators, including Peleska of Czechoslovakia, Tsukerman of the Soviet Union, and Lown and his group7 in this country.
Alternating or Direct Current
Whether alternating or direct current is used, electrical defibrillation requires a high-energy impulse of short duration to be passed across the myocardium, either between two concave paddles closely applied to the heart (internal defibrillation) or through the chest wall using two flat paddles (external defibrillation). The total electrical energy delivered to the heart muscle depends not only on the electrical current, but also on the resistance of the heart, bony cage, and skin to its passage.
Much of the confusion in the earlier literature comparing alternating with direct current defibrillation relates to the infinite wave forms obtainable using direct current discharge. In contrast, the alternating current wave form is constant and determined at the power station as a sinusoidalCirculation, Volume XLVII, shaped impulse with a frequency of 60Hz but at a variable voltage level. A minimal current of 1 amp is needed to bring all the heart muscles instantaneously to the same refractory point. The required voltage for internal defibrillation is 100 v and the power 100 w. Electric energy (power X time) is not synonymous with electrical current, and for internal defibrillation the energy needed would be about 20 joules (wsec). In contrast, for external defibrillation a sixfold current increase is used producing an energy of 360 joules.
With direct current defibrillators, the duration of the impulse is short (1.5-4 msec) . The wave form is shaped by adding varying amounts of inductance to the circuit, thereby insuring minimal biologic damage to its passage across the tissues of the body, particularly the heart. The important difference between alternating and direct current defibrillation is that DC develops many times the power of AC. Direct current discharge, however, is much shorter than alternating current (3 msec vs 200 msec).
The This is a particularly gratifying dysrhythmia to treat; the initial success rate is 97% and electric energies needed are low, the average setting being 50 joules. There should therefore be no hesitation in recommending electroversion for any ventricular tachycardia which fails to respond quickly to emergency drug therapy. Caution has to be advised, however, when ventricular tachycardia is digitalis-induced; electroversion can now only be recommended under the most exceptional circumstances and drug therapy is the treatment of choice.
Ventricular Fibrillation
Controlled clinical trials of direct current (unsynchronized) vs alternating current for defibrillation are difficult to design, but there is good animal experimental work to indicate the superiority of DC,13 and in clinical practice successful resuscitation (patient leaving hospital) has been reported in more than 50% of patients treated by DC shock and well conducted principles of resuscitation.32 The initial energy setting should be 200 joules, increasing by 100-joule increments if needed.
Complications
Complications occur more frequently than initially predicted, and do not only relate to drugs given to maintain sinus rhythm. Indeed, an incidence of 14.5% among 220 consecutive patients has been reported;33 these did not include minor complications such as superficial skin burns due to poor preparation of the skin or transient rhythm disturbances after the shock. Included, however, were the following.
Raised Levels of the Serum Enzymes LDH and CPK (10%) Their origin, however, is still uncertain Mandecki et al. 34 consider skeletal muscle damage as the cause, but as other signs of myocardial damage frequently coexist when the serum enzyme levels are raised, the matter awaits definitive study.
Hypotension (3%)
Hypotension is more common when higher electric energies are used, and may persist for several hours, frequently requiring no particular intervention, but the patient should be carefully observed.
ECG Evidence of Myocardial Damage (3%)
Patterns of myocardial infarction may follow the shock and persist for many months; they are most common following electroversion at high energy settings.
Pulmonary and Systemic Emboli (1.4%)
The incidence is similar to that following quinidine conversion of rhythm disturbances but does indicate the need for anticoagulant cover (see below).
Ventricular Rhythm Disturbances
Ventricular premature beats and tachycardia are common at low energy settings when the patient is heavily digitalized, and at high energy level settings even in the absence of any digitalis preparation. Should a ventricular dysrhythmia follow the first shock, an intravenous antidysrhythmic drug, as previously recommended, should be given before increasing to high energy settings.
Pulmonary Edema and Increase in Heart Size
These may occur in -3% of patients coming on within 1-3 hours of treatment.35 Unlike other major complications, they occur only in patients actually reverted to sinus rhythm. While Lown considers Circulation, Volume XLVII, June 1973 pulmonary emboli as a possible cause, others believe that following electroversion there is considerable depression of the mechanical function of the left atrium.36 Any additional obstruction to flow across the mitral valve, any lessening of left ventricular wall compliance or left ventricular dysfunction will aggravate the situation and may result in pulmonary edema.
The incidence of complications relates to the energy level setting, being 6% at 150 joules but rising to exceed 30% at a setting of 400 joules. One can conclude, therefore, that there is rarely an indication for exceeding a 300-joules setting in patients presenting with long-standing rhythm disturbances, particularly atrial fibrillation of more than 5 years' duration.
Follow-up Studies
While the initial success rate is remarkably good, direct current shock is disappointing in long-term follow-up studies, particularly when atrial fibrillation is treated. 17, 20, 37 Reversion to atrial fibrillation is most likely by the end of the first month of electroversion, and not infrequently occurs within the first day. Those in whom atrial fibrillation has persisted for more than 3 years, those with significant underlying heart disease, or with considerable overall enlargement of the heart are particularly liable to revert to atrial fibrillation. Those clinical and experimental observations suggest that the toxic cardiac effects of these drugs may even be enhanced by high energy electric current; they therefore advise caution in their routine use. More recently, quinidine bisulfate as a long-acting preparation has been extensively investigated in an attempt to maintain sinus rhythm following DC shock.43 Even when a long-acting preparation is controlled with adequate blood levels, sinus rhythm persists only for a slightly longer period of time, and furthermore, the incidence of complications with quinidine may still be high.
It can be concluded, nevertheless, that quinidine or some other antidysrhythmic drug should be considered for any patient who has reverted to his original rhythm disturbance, and in whom sinus rhythm is important. The chances of sinus rhythm persisting, however, are not good, even when adequate blood levels are maintained.
Digitalis and Electroversion
Lown, Kleiger, and Williams44 reported that in experimental animals the DC threshold for the emergence of ventricular tachycardia fell to 0.2 joules in the presence of heavy digitalization.
In man, the counterpart of these observations is demonstrated by ventricular premature beats, tachycardia, or even fibrillation being precipitated by the DC shock in heavily digitalized patients. 17' 20, 31 In the presence of a known digitalis-induced rhythm disturbance, electroversion should therefore rarely be used, for despite the very occasional record of a successful outcome, fatal ventricular fibrillation may follow the shock, even when properly synchronized.45
Anticoagulants and Electroversion
The need for and efficiency of anticoagulant protection has been the subject of much debate, in the absence of any well-controlled study. Such a study has now been reported46 demonstrating a statistical benefit in a group of patients who had electroversion under anticoagulant control. Unless a contraindication to its use is present, all patients going forward to electroversion should be protected by anticoagulant therapy, particularly patients with recent cardiac infarction, chronic coronary heart disease, mitral valvar disease, cardiomyopathy, and prosthetic heart valves when a coumadin derivative should be given or heparin used if the indication for DC shock is urgent. As the risk of reversion to the original rhythm disturbance is highest within the first month of treatment, it is wise to maintain oral anticoagulant therapy for at least 4 weeks after successful DC shock when it may be discontinued unless the underlying heart disease requires its continuance.
Electric defibrillation of the heart, particularly synchronized DC shock, is an exciting advance but further effort is needed to uncover the basic mechanisms of rhythm disturbances, thereby encouraging the development of more physiologic approaches to their treatment and particularly to the maintenance of sinus rhythm thereafter.
